Top

Reviews in Endocrine and Metabolic Disorders

Published in:

01-03-2010

The economic consequences of diabetes and cardiovascular disease in the United States

Authors: Miguel A. Ariza, Varsha G. Vimalananda, James L. Rosenzweig

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 1/2010

Abstract

Diabetes-related care and complications constitute a significant proportion of the United States’ (US) health care expenditure. Of these complications, cardiovascular disease (CVD) is a major component. Higher morbidity and mortality rates translate to higher costs of care in patients with diabetes compared to those who do not have the disease. Minorities bear a disproportionate burden of diabetes and CVD. We review this disparity and examine potential etiologies for it in Hispanics and African-Americans, the two largest minority groups in the US. We examine strategies in these populations that may improve outcomes in diabetes and CVD, potentially decreasing health care costs.

Kaiser Family Foundation. Snapshots: Healthcare Spending in the United States and OECD Countries. 2007(August 31).

Centers for Medicare and Medicaid Services. National Health Expenditures 2007 Highlights. 2007(09/01).

Office of the Actuary, Centers for Medicare and Medicaid Services, U.S. Department of Health and Human Services. National Health Expenditure Data Highlights. 2009; Available at: http://www.cms.hhs.gov/NationalHealthExpendData/downloads/highlights.pdf. Accessed 08/25, 2009.

National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics, 2007 fact sheet. 2008(08/28).

American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;31(3):596–615.

Centers for Disease Control and Prevention (CDC). Self-reported heart disease and stroke among adults with and without diabetes—United States, 1999-2001. MMWR—Morb Mort Wkly Rep. 2003;52(44):1065–70.

Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979;59(1):8–13.PubMed

Natali A, Vichi S, Landi P, Severi S, L’Abbate A, Ferrannini E. Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia. 2000;43(5):632–41.PubMed

Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16(2):434–44.PubMed

10.

Fu AZ, Qiu Y, Radican L, Wells BJ. Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care. 2009;32(12):2187–92.PubMed

11.

O’Brien JA, Shomphe LA, Kavanagh PL, Raggio G, Caro JJ. Direct medical costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care. 1998;21(7):1122–8.PubMed

12.

Caro JJ, Ward AJ, O’Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care. 2002;25(3):476–81.PubMed

13.

Kaiser Family Foundation. Trends in Health Care Costs and Spending. 2007; Available at: http://www.kff.org/insurance/upload/7692.pdf. Accessed 08/25, 2009.

14.

Russo CA, Jiang HJ. Hospital Stays among Patients with Diabetes, 2004. HCUP Statistical Brief #17. 2006; Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb17.pdf. Accessed 08/25, 2009.

15.

Nichols GA, Brown JB. The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes. Diabetes Care. 2002;5(3):482.

16.

Clark MA, Bakhai A, Lacey MJ, Pelletier EM, Cohen DJ. Clinical and economic outcomes of percutaneous coronary interventions in the elderly: an analysis of Medicare claims data. Circulation. 2004;110(3):259–64.PubMed

17.

Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med. 2007;11(11):1145–51.

18.

Bradshaw D, Norman R, Pieterse D, Levitt NS, South African Comparative Risk Assessment Collaborating Group. Estimating the burden of disease attributable to diabetes in South Africa in 2000. South African Medical Journal. 2007;97(8 Pt 2):700–6.PubMed

19.

Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care. 2009;32(2):287–94.PubMed

20.

Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med. 2004;164(19):2147–55.PubMed

21.

Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med. 2005;165(16):1910–6.PubMed

22.

Nichols GA, Brown JB. Higher medical care costs accompany impaired fasting glucose. Diabetes Care. 2005;28(9):2223–9.PubMed

23.

Diabetes Prevention Program Research Group. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care. 2003;26(9):2518–23.

24.

Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142(5):323–32.PubMed

25.

CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA. 2002;287(19):2542–51.

26.

Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care. 2006;29(9):2114–6.PubMed

27.

U.S. Census Bureau, Population Division, Population Projections Branch. National Population Projections. 2008;2009(08/25).

28.

Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281(14):1291–7.PubMed

29.

Sundquist J, Winkleby MA, Pudaric S. Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988-1994. Third National Health and Nutrition Examination Survey. J Am Geriatr Soc. 2001;49(2):109–16.PubMed

30.

Centers for Disease Control and Prevention (CDC). National Diabetes Fact Sheet: general information and national estimates on diabetes in the United States, 2007. 2009; Available at: http://www.cdc.gov. Accessed 10/22, 2009.

31.

Perez Gomez G, Huffman FG. Risk factors for type 2 diabetes and cardiovascular diseases in Hispanic adolescents. J Adolesc Health. 2008;43(5):444–50.PubMed

32.

Mitchell BD, Almasy LA, Rainwater DL, Schneider JL, Blangero J, Stern MP, et al. Diabetes and hypertension in Mexican American families: relation to cardiovascular risk. Am J Epidemiol. 1999;149(11):1047–56.PubMed

33.

West SK, Klein R, Rodriguez J, Munoz B, Broman AT, Sanchez R, et al. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care. 2001;24(7):1204–9.PubMed

34.

Lindeman RD, Romero LJ, Hundley R, Allen AS, Liang HC, Baumgartner RN, et al. Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population. Diabetes Care. 1998;21(6):959–66.PubMed

35.

Residori L, Garcia-Lorda P, Flancbaum L, Pi-Sunyer FX, Laferrere B. Prevalence of co-morbidities in obese patients before bariatric surgery: effect of race. Obes Surg. 2003;13(3):333–40.PubMed

36.

Hertz RP, Unger AN, Ferrario CM. Diabetes, hypertension, and dyslipidemia in Mexican Americans and non-Hispanic whites. Am J Prev Med. 2006;30(2):103–10.PubMed

37.

Harris MI. Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes. Diabetes Care. 2001;24(3):454–9.PubMed

38.

Haffner SM. Hypertension in the San Antonio Heart Study and the Mexico City diabetes Study: clinical and metabolic correlates. Public Health Rep. 1996;111 Suppl 2:11–4.PubMed

39.

Rewers M, Shetterly SM, Hamman RF. Hypertension among rural Hispanics and non-Hispanic whites: the San Luis Valley Diabetes Study. Public Health Rep. 1996;111 Suppl 2:27–9.PubMed

40.

Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, Gabriel R, Williams K, Gonzalez-Villalpando C, et al. Prevalence of hypertension in Hispanic and non-Hispanic white populations. Hypertension. 2002;39(2):203–8.PubMed

41.

Budoff MJ, Nasir K, Mao S, Tseng PH, Chau A, Liu ST, et al. Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis. 2006;187(2):343–50.PubMed

42.

Cowie CC, Harris MI. Ambulatory medical care for non-Hispanic whites, African-Americans, and Mexican-Americans with NIDDM in the U.S. Diabetes Care. 1997;20(2):142–7.PubMed

43.

Morrato EH, Hill JO, Wyatt HR, Ghushchyan V, Sullivan PW. Are health care professionals advising patients with diabetes or at risk for developing diabetes to exercise more? Diabetes Care. 2006;29(3):543–8.PubMed

44.

Correa-de-Araujo R, Stevens B, Moy E, Nilasena D, Chesley F, McDermott K. Gender differences across racial and ethnic groups in the quality of care for acute myocardial infarction and heart failure associated with comorbidities. Women’s Health Issues. 2006;16(2):44–55.PubMed

45.

Baumann LC, Chang MW, Hoebeke R. Clinical outcomes for low-income adults with hypertension and diabetes. Nurs Res. 2002;51(3):191–8.PubMed

46.

Mainous III AG, Diaz VA, Koopman RJ, Everett CJ. Quality of care for Hispanic adults with diabetes. Fam Med. 2007;39(5):351–6.

47.

Wendel CS, Shah JH, Duckworth WC, Hoffman RM, Mohler MJ, Murata GH. Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study. BMC Health Serv Res. 2006;6:58.PubMed

48.

Ting HH, Bradley EH, Wang Y, Lichtman JH, Nallamothu BK, Sullivan MD, et al. Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction. Arch Intern Med. 2008;168(9):959–68.PubMed

49.

Swenson CJ, Trepka MJ, Rewers MJ, Scarbro S, Hiatt WR, Hamman RF. Cardiovascular disease mortality in Hispanics and non-Hispanic whites. Am J Epidemiol. 2002;156(10):919–28.PubMed

50.

Akerblom JL, Costa R, Luchsinger JA, Manly JJ, Tang MX, Lee JH, et al. Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders. Age Ageing. 2008;37(2):207–13.PubMed

51.

Winkleby MA. Concerns and misconceptions about cardiovascular disease risk factors: a focus group evaluation with low-income hispanic women. Hisp J Behav Sci. 1998;20(2):192–211.

52.

Kington RS, Smith JP. Socioeconomic status and racial and ethnic differences in functional status associated with chronic diseases. Am J Public Health. 1997;87(5):805–10.PubMed

53.

Lorenzo C, Williams K, Gonzalez-Villalpando C, Stern MP, Hazuda HP, Haffner SM. Lower hypertension risk in Mexico City than in San Antonio. Am J Hypertens. 2005;18(3):385–91.PubMed

54.

Kandula NR, Diez-Roux AV, Chan C, Daviglus ML, Jackson SA, Ni H, et al. Association of acculturation levels and prevalence of diabetes in the multi-ethnic study of atherosclerosis (MESA). Diabetes Care. 2008;31(8):1621–8.PubMed

55.

Nettleton JA, Steffen LM, Ni H, Liu K, Jacobs Jr DR. Dietary patterns and risk of incident type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2008;31(9):1777–82.PubMed

56.

Alexander H, Lockwood LP, Harris MA, Melby CL. Risk factors for cardiovascular disease and diabetes in two groups of Hispanic Americans with differing dietary habits. J Am Coll Nutr. 1999;18(2):127–36.PubMed

57.

California Medi-Cal Type 2 Diabetes Study Group. Closing the gap: effect of diabetes case management on glycemic control among low-income ethnic minority populations: the California Medi-Cal type 2 diabetes study. Diabetes Care. 2004;27(1):95–103.

58.

Benjamin EM, Schneider MS, Hinchey KT. Implementing practice guidelines for diabetes care using problem-based learning. A prospective controlled trial using firm systems. Diabetes Care. 1999;22(10):1672–8.PubMed

59.

Eamranond PP, Legedza AT, Diez-Roux AV, Kandula NR, Palmas W, Siscovick DS, et al. Association between language and risk factor levels among Hispanic adults with hypertension, hypercholesterolemia, or diabetes. Am Heart J. 2009;157(1):53–9.PubMed

60.

Cheng EM, Chen A, Cunningham W. Primary language and receipt of recommended health care among Hispanics in the United States. J Gen Intern Med. 2007;22 Suppl 2:283–8.PubMed

61.

Rosal MC, Goins KV, Carbone ET, Cortes DE. Views and preferences of low-literate Hispanics regarding diabetes education: results of formative research. Health Educ Behav. 2004;31(3):388–405.PubMed

62.

Hazuda HP. Hypertension in the San Antonio Heart Study and the Mexico City Diabetes Study: sociocultural correlates. Public Health Rep. 1996;111 Suppl 2:18–21.PubMed

63.

Sarkar U, Fisher L, Schillinger D. Is self-efficacy associated with diabetes self-management across race/ethnicity and health literacy? Diabetes Care. 2006;29(4):823–9.PubMed

64.

Schillinger D, Barton LR, Karter AJ, Wang F, Adler N. Does literacy mediate the relationship between education and health outcomes? A study of a low-income population with diabetes. Public Health Rep. 2006;121(3):245–54.PubMed

65.

Powell CK, Hill EG, Clancy DE. The relationship between health literacy and diabetes knowledge and readiness to take health actions. Diabetes Educ. 2007;33(1):144–51.PubMed

66.

Cavanaugh K, Huizinga MM, Wallston KA, Gebretsadik T, Shintani A, Davis D, et al. Association of numeracy and diabetes control. Ann Intern Med. 2008;148(10):737–46.PubMed

67.

Kuo YF, Raji MA, Markides KS, Ray LA, Espino DV, Goodwin JS. Inconsistent use of diabetes medications, diabetes complications, and mortality in older Mexican Americans over a 7-year period: data from the Hispanic established population for the epidemiologic study of the elderly. Diabetes Care. 2003;26(11):3054–60.PubMed

68.

Black SA. Increased health burden associated with comorbid depression in older diabetic Mexican Americans. Results from the Hispanic Established Population for the Epidemiologic Study of the Elderly survey. Diabetes Care. 1999;22(1):56–64.PubMed

69.

Quatromoni PA, Milbauer M, Posner BM, Carballeira NP, Brunt M, Chipkin SR. Use of focus groups to explore nutrition practices and health beliefs of urban Caribbean Latinos with diabetes. Diabetes Care. 1994;17(8):869–73.PubMed

70.

Lipton RB, Losey LM, Giachello A, Mendez J, Girotti MH. Attitudes and issues in treating Latino patients with type 2 diabetes: views of healthcare providers. Diabetes Educ. 1998;24(1):67–71.PubMed

71.

Caban A, Walker EA. A systematic review of research on culturally relevant issues for Hispanics with diabetes. Diabetes Educ. 2006;32(4):584–95.PubMed

72.

Galvez MP, Morland K, Raines C, Kobil J, Siskind J, Godbold J, et al. Race and food store availability in an inner-city neighbourhood. Public Health Nutr. 2008;11(6):624–31.PubMed

73.

Piette JD, Bibbins-Domingo K, Schillinger D. Health care discrimination, processes of care, and diabetes patients’ health status. Patient Educ Couns. 2006;60(1):41–8.PubMed

74.

Kaushik VP, Al Snih S, Ray LA, Raji MA, Markides KS, Goodwin JS. Factors associated with seven-year incidence of diabetes complications among older Mexican Americans. Gerontology. 2007;53(4):194–9.PubMed

75.

Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care. 1998;21(7):1167–72.PubMed

76.

Lisabeth LD, Smith MA, Sanchez BN, Brown DL. Ethnic disparities in stroke and hypertension among women: the BASIC project. Am J Hypertens. 2008;21(7):778–83.PubMed

77.

Zahuranec DB, Brown DL, Lisabeth LD, Gonzales NR, Longwell PJ, Eden SV, et al. Differences in intracerebral hemorrhage between Mexican Americans and non-Hispanic whites. Neurology. 2006;66(1):30–4.PubMed

78.

Sacco RL, Boden-Albala B, Abel G, Lin IF, Elkind M, Hauser WA, et al. Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke. 2001;32(8):1725–31.PubMed

79.

Frey JL, Jahnke HK, Bulfinch EW. Differences in stroke between white, Hispanic, and Native American patients: the Barrow Neurological Institute stroke database. Stroke. 1998;29(1):29–33.PubMed

80.

Ottenbacher KJ, Ostir GV, Peek MK, Markides KS. Diabetes mellitus as a risk factor for stroke incidence and mortality in Mexican American older adults. J Gerontol A Biol Sci Med Sci. 2004;59(6):M640–5.PubMed

81.

Otiniano ME, Du XL, Ottenbacher K, Markides KS. The effect of diabetes combined with stroke on disability, self-rated health, and mortality in older Mexican Americans: results from the Hispanic EPESE. Arch Phys Med Rehabil. 2003;84(5):725–30.PubMed

82.

Young BA, Maynard C, Reiber G, Boyko EJ. Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans. Diabetes Care. 2003;26(2):495–501.PubMed

83.

Fraser-Bell S, Wu J, Klein R, Azen SP, Hooper C, Foong AW, et al. Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study. Am J Ophthalmol. 2008;145(2):308–16.PubMed

84.

Cotter SA, Varma R, Ying-Lai M, Azen SP, Klein R, Los Angeles Latino Eye Study Group. Causes of low vision and blindness in adult Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2006;113(9):1574–82.PubMed

85.

Bronner YL. Nutritional status outcomes for children: ethnic, cultural, and environmental contexts. J Am Diet Assoc. 1996;96(9):891–903.PubMed

86.

Metghalchi S, Rivera M, Beeson L, Firek A, De Leon M, Balcazar H, et al. Improved clinical outcomes using a culturally sensitive diabetes education program in a Hispanic population. Diabetes Educ. 2008;34(4):698–706.PubMed

87.

Chodosh J, Morton SC, Mojica W, Maglione M, Suttorp MJ, Hilton L, et al. Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med. 2005;143(6):427–38.PubMed

88.

Bjorsen SS. Review: group-based education in self-management strategies improves outcomes in type 2 diabetes mellitus. Evid Based Med. 2005;10(6):173.

89.

Mauldon M, Melkus GD, Cagganello M. Tomando Control: a culturally appropriate diabetes education program for Spanish-speaking individuals with type 2 diabetes mellitus—evaluation of a pilot project. Diabetes Educ. 2006;32(5):751–60.PubMed

90.

Peek ME, Cargill A, Huang ES. Diabetes health disparities: a systematic review of health care interventions. Med Care Res Rev. 2007;64(5 Suppl):101S–56S.PubMed

91.

Brown SA, Garcia AA, Kouzekanani K, Hanis CL. Culturally competent diabetes self-management education for Mexican Americans: the Starr County border health initiative. Diabetes Care. 2002;25(2):259–68.PubMed

92.

Corkery E, Palmer C, Foley ME, Schechter CB, Frisher L, Roman SH. Effect of a bicultural community health worker on completion of diabetes education in a Hispanic population. Diabetes Care. 1997;20(3):254–7.PubMed

93.

Fanning EL, Selwyn BJ, Larme AC, DeFronzo RA. Improving efficacy of diabetes management using treatment algorithms in a mainly Hispanic population. Diabetes Care. 2004;27(7):1638–46.PubMed

94.

Davidson MB. Effect of nurse-directed diabetes care in a minority population. Diabetes Care. 2003;26(8):2281–7.PubMed

95.

Walker EA, Schechter CB, Caban A, Basch CE. Telephone intervention to promote diabetic retinopathy screening among the urban poor. Am J Prev Med. 2008;34(3):185–91.PubMed

96.

Wheeler LA, Wheeler ML, Ours P, Swider C. Evaluation of computer-based diet education in persons with diabetes mellitus and limited educational background. Diabetes Care. 1985;8(6):537–44.PubMed

97.

Gerber BS, Brodsky IG, Lawless KA, Smolin LI, Arozullah AM, Smith EV, et al. Implementation and evaluation of a low-literacy diabetes education computer multimedia application. Diabetes Care. 2005;28(7):1574–80.PubMed

98.

Volandes AE, Ariza M, Abbo ED, Paasche-Orlow M. Overcoming educational barriers for advance care planning in Latinos with video images. J Palliat Med. 2008;11(5):700–6.PubMed

99.

Dannenbaum D, Verronneau M, Torrie J, Smeja H, Robinson E, Dumont C, et al. Comprehensive computerized diabetes registry. Serving the Cree of Eeyou Istchee (eastern James Bay). Can Fam Physician. 1999;45:364–70.PubMed

100.

Campion FX, Tully GL, Barrett JA, Andre P, Sweeney A. Improving quality of care using a diabetes registry and disease management services in an integrated delivery network. Dis Manag. 2005;8(4):245–52.PubMed

101.

Zgibor JC, Orchard TJ, Saul M, Piatt G, Ruppert K, Stewart A, et al. Developing and validating a diabetes database in a large health system. Diabetes Res Clin Pract. 2007;75(3):313–9.PubMed

102.

Bindon J, Dressler WW, Gilliland MJ, Crews DE. A cross-cultural perspective on obesity and health in three groups of women: the Mississippi Choctaw, American Samoans, and African Americans. Coll Antropol. 2007;31(1):47–54.PubMed

103.

104.

Diaz VA, Mainous 3rd AG, Koopman RJ, Geesey ME. Undiagnosed obesity: implications for undiagnosed hypertension, diabetes, and hypercholesterolemia. Fam Med. 2004;36(9):639–44.PubMed

105.

Wilson DM, Wang Y, Cullen KW, Baranowski T, Himes JH, Gross M, et al. Assessing weight-related biochemical cardiovascular risk factors in African-American girls. Obes Res. 2004;12(Suppl):73S–83S.PubMed

106.

Schneider EC, Zaslavsky AM, Epstein AM. Racial disparities in the quality of care for enrollees in medicare managed care. JAMA. 2002;287(10):1288–94.PubMed

107.

Carter JS, Pugh JA, Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med. 1996;125(3):221–32.PubMed

108.

Feinglass J, Abadin S, Thompson J, Pearce WH. A census-based analysis of racial disparities in lower extremity amputation rates in Northern Illinois, 1987-2004. J Vasc Surg. 1001;47(5):1001–7. discussion 1007.

109.

Brothers TE, Robison JG, Elliott BM. Diabetes mellitus is the major risk factor for African Americans who undergo peripheral bypass graft operation. J Vasc Surg. 1999;29(2):352–9.PubMed

110.

Davis SK, Liu Y, Gibbons GH. Disparities in trends of hospitalization for potentially preventable chronic conditions among African Americans during the 1990s: implications and benchmarks. Am J Public Health. 2003;93(3):447–55.PubMed

111.

Asher CR, Topol EJ, Moliterno DJ. Insights into the pathophysiology of atherosclerosis and prognosis of black Americans with acute coronary syndromes. AmHeart J. 1999;138(6 Pt 1):1073–81.PubMed

112.

Vaccaro O, Stamler J, Neaton JD. Sixteen-year coronary mortality in black and white men with diabetes screened for the Multiple Risk Factor Intervention Trial (MRFIT). Int J Epidemiol. 1998;27(4):636–41.PubMed

113.

Rosenberg L, Palmer JR, Rao RS, Adams-Campbell LL. Risk factors for coronary heart disease in African American women. Am J Epidemiol. 1999;150(9):904–9.PubMed

114.

Stevens J, Plankey MW, Williamson DF, Thun MJ, Rust PF, Palesch Y, et al. The body mass index-mortality relationship in white and African American women. Obes Res. 1998;6(4):268–77.PubMed

115.

Okosun IS, Cooper RS, Rotimi CN, Osotimehin B, Forrester T. Association of waist circumference with risk of hypertension and type 2 diabetes in Nigerians, Jamaicans, and African-Americans. Diabetes Care. 1998;21(11):1836–42.PubMed

116.

Qureshi AI, Suri MF, Zhou J, Divani AA. African American women have poor long-term survival following ischemic stroke. Neurology. 2006;67(9):1623–9.PubMed

117.

Dwyer EM, Asif M, Ippolito T, Gillespie M. Role of hypertension, diabetes, obesity, and race in the development of symptomatic myocardial dysfunction in a predominantly minority population with normal coronary arteries. Am Heart J. 2000;139(2 Pt 1):297–304.PubMed

118.

Ettinger LM, Freeman K, DiMartino-Nardi JR, Flynn JT. Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus. J Pediatr. 2005;147(1):67–73.PubMed

119.

Smith GL, Shlipak MG, Havranek EP, Masoudi FA, McClellan WM, Foody JM, et al. Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation. 2005;111(10):1270–7.PubMed

120.

Young BA, Maynard C, Boyko EJ. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care. 2003;26(8):2392–9.PubMed

121.

Emanuele N, Sacks J, Klein R, Reda D, Anderson R, Duckworth W, et al. Ethnicity, race, and baseline retinopathy correlates in the Veterans’ Affairs Diabetes Trial. Diabetes Care. 2005;28(8):1954–8.PubMed

122.

Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care. 1998;21(8):1230–5.PubMed

123.

Tanaka M, Jaamaa G, Kaiser M, Hills E, Soim A, Zhu M, et al. Racial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study. Am J Public Health. 2007;97(1):163–70.PubMed

124.

Ruland S, Raman R, Chaturvedi S, Leurgans S, Gorelick PB, AAASPS Investigators. African American Antiplatelet Stroke Prevention Study. Awareness, treatment, and control of vascular risk factors in African Americans with stroke. Neurology. 2003;60(1):64–8.PubMed

125.

Cook CB, Ziemer DC, El-Kebbi IM, Gallina DL, Dunbar VG, Ernst KL, et al. Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care. 1999;22(9):1494–500.PubMed

126.

Blanchard MA, Rose LE, Taylor J, McEntee MA, Latchaw LL. Using a focus group to design a diabetes education program for an African American population. Diabetes Educ. 1999;25(6):917–24.PubMed

127.

Diez-Roux AV, Northridge ME, Morabia A, Bassett MT, Shea S. Prevalence and social correlates of cardiovascular disease risk factors in Harlem. Am J Public Health. 1999;89(3):302–7.PubMed

128.

Frank D, Grubbs L. A faith-based screening/education program for diabetes, CVD, and stroke in rural African Americans. ABNF J. 2008;19(3):96–101.PubMed

129.

Snella KA, Canales AE, Irons BK, Sleeper-Irons RB, Villarreal MC, Levi-Derrick VE, et al. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc (2003). 2006;46(3):370–7.

130.

Becker DM, Yanek LR, Johnson Jr WR, Garrett D, Moy TF, Reynolds SS, et al. Impact of a community-based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease. Circulation. 2005;111(10):1298–304.PubMed

131.

Nine SL, Lakies CL, Jarrett HK, Davis BA. Community-based chronic disease management program for African Americans. Outcomes Manag. 2003;7(3):106–12.PubMed

132.

Two Feathers J, Kieffer EC, Palmisano G, Anderson M, Sinco B, Janz N, et al. Racial and ethnic approaches to community health (REACH) Detroit partnership: improving diabetes-related outcomes among African American and Latino adults. Am J Public Health. 2005;95(9):1552–60.PubMed

133.

Hill-Briggs F, Renosky R, Lazo M, Bone L, Hill M, Levine D, et al. Development and pilot evaluation of literacy-adapted diabetes and CVD education in urban, diabetic African Americans. J Gen Intern Med. 2008;23(9):1491–4.PubMed

134.

Plescia M, Herrick H, Chavis L. Improving health behaviors in an African American community: the Charlotte Racial and Ethnic Approaches to Community Health project. Am J Public Health. 2008;98(9):1678–84.PubMed

135.

Lindquist CH, Gower BA, Goran MI. Role of dietary factors in ethnic differences in early risk of cardiovascular disease and type 2 diabetes. Am J Clin Nutr. 2000;71(3):725–32.PubMed

Title: The economic consequences of diabetes and cardiovascular disease in the United States
Authors: Miguel A. Ariza
Varsha G. Vimalananda
James L. Rosenzweig
Publication date: 01-03-2010
Publisher: Springer US
Published in: Reviews in Endocrine and Metabolic Disorders / Issue 1/2010
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI: https://doi.org/10.1007/s11154-010-9128-2

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

The economic consequences of diabetes and cardiovascular disease in the United States

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications

Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus

Impact of cardiovascular outcomes on the development and approval of medications for the treatment of diabetes mellitus

Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community

Revascularization for coronary artery disease in diabetes mellitus: Angioplasty, stents and coronary artery bypass grafting

Overview of the importance of glycaemic control for cardiovascular events in the in-and out-patient setting

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page